(Q52098562)

22 April 2018

title

Oral administration of chronic physostigmine does not improve cognitive or mnesic performances in Alzheimer's presenile dementia. (English)

1 reference

22 April 2018

author name string

Caltagirone C

series ordinal

1

1 reference

22 April 2018

Gainotti G

series ordinal

2

1 reference

22 April 2018

Masullo C

series ordinal

3

1 reference

22 April 2018

publication date

1 May 1982

1 reference

22 April 2018

International Journal of Neuroscience

published in

1 reference

22 April 2018

volume

16

1 reference

22 April 2018

page(s)

247-249

1 reference

22 April 2018

issue

3-4

1 reference

22 April 2018

Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

Validity of some neuropsychological tests in the assessment of mental deterioration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

Memory and cognitive function in the elderly. A preliminary trial of physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207458209147153

10.3109/00207458209147153

21 January 2018

Identifiers

DOI

1 reference

22 April 2018

PubMed ID

7169287

1 reference

22 April 2018